Cite
HARVARD Citation
Barriuso, J. et al. (2018). Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours. Cancer treatment reviews. pp. 209-222. [Online].